Gastric tolerability and prolonged prostaglandin inhibition in the brain with a nitric oxide-releasing flurbiprofen derivative, NCX-2216[3-[4-(2-fluoro-alpha-methyl-[1,1'-biphenyl]-4-acetyloxy)-3-methoxyphenyl]-2-propenoicacid-4-nitrooxybutyl ester] (2004)
- Authors:
- USP affiliated authors: MUSCARA, MARCELO NICOLAS - ICB ; NUCCI, GILBERTO DE - ICB
- Unidade: ICB
- Assunto: FARMACOLOGIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of Pharmacology and Experimental Therapeutics
- ISSN: 0022-3565
- Volume/Número/Paginação/Ano: v. 309, p. 626-633, 2004
-
ABNT
WALLACE, John L. et al. Gastric tolerability and prolonged prostaglandin inhibition in the brain with a nitric oxide-releasing flurbiprofen derivative, NCX-2216[3-[4-(2-fluoro-alpha-methyl-[1,1'-biphenyl]-4-acetyloxy)-3-methoxyphenyl]-2-propenoicacid-4-nitrooxybutyl ester]. Journal of Pharmacology and Experimental Therapeutics, v. 309, p. 626-633, 2004Tradução . . Acesso em: 28 dez. 2025. -
APA
Wallace, J. L., Muscará, M. N., De Nucci, G., Zamuner, S. R., Cirino, G., Soldato, P. del, & Ongini, E. (2004). Gastric tolerability and prolonged prostaglandin inhibition in the brain with a nitric oxide-releasing flurbiprofen derivative, NCX-2216[3-[4-(2-fluoro-alpha-methyl-[1,1'-biphenyl]-4-acetyloxy)-3-methoxyphenyl]-2-propenoicacid-4-nitrooxybutyl ester]. Journal of Pharmacology and Experimental Therapeutics, 309, 626-633. -
NLM
Wallace JL, Muscará MN, De Nucci G, Zamuner SR, Cirino G, Soldato P del, Ongini E. Gastric tolerability and prolonged prostaglandin inhibition in the brain with a nitric oxide-releasing flurbiprofen derivative, NCX-2216[3-[4-(2-fluoro-alpha-methyl-[1,1'-biphenyl]-4-acetyloxy)-3-methoxyphenyl]-2-propenoicacid-4-nitrooxybutyl ester]. Journal of Pharmacology and Experimental Therapeutics. 2004 ; 309 626-633.[citado 2025 dez. 28 ] -
Vancouver
Wallace JL, Muscará MN, De Nucci G, Zamuner SR, Cirino G, Soldato P del, Ongini E. Gastric tolerability and prolonged prostaglandin inhibition in the brain with a nitric oxide-releasing flurbiprofen derivative, NCX-2216[3-[4-(2-fluoro-alpha-methyl-[1,1'-biphenyl]-4-acetyloxy)-3-methoxyphenyl]-2-propenoicacid-4-nitrooxybutyl ester]. Journal of Pharmacology and Experimental Therapeutics. 2004 ; 309 626-633.[citado 2025 dez. 28 ] - Pre-treatment with capsaicin potentiates superoxide anion release by circulating neutrophils from endotoxemic rats
- Superoxide dismutase isoforms 1 and 2 in lumbar spinal cord of neonatal rats after sciatic nerve transection and melatonin treatment
- Role of TNF-'alfa' and LTB, in the enhanced airway neutrophil recruitment of rats treated neonatally with capsaicin
- Upregulation of muscarinic receptors by long-term nitric oxide inhibition in the rat ileum
- Mechanisms involved in the enhancement of allergic airways neutrophil influx by permanent C-fiber degeneration in rats
- Effects of neonatal capsaicin treatment in the neutrophil production, and expression of preprotachykinin-I and tachykinin receptors in the rat bone marrow
- Expression and activity of nitric oxide synthase isoforms in rat brain during the development of experimental allergic encephalomyelitis
- Blockade of renin-angiotensin system prevents bladder dysfunction in two-kidney one-clip hypertensive rats
- Quantification of methyldopa in human plasma by high-performance liquid chromatography-electrospray tandem mass spectrometry application to a bioequivalence study
- Lack of correlation between nitrotyrosine (NT) -modified protein expression, superoxide anion SUP and nitric oxide (NO) production in endotoxemic rats
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
